Statins, HMG-CoA reductase inhibitors, are considered the first line treatment of
hyperlipidemia to reduce the risk of atherosclerotic cardiovascular diseases. The prevalence of …

Background Five hundred milligrams of intravenous (IV) sotrovimab has been shown to be
well tolerated and efficacious against pre-Omicron strains in treating patients with mild to …

Sotrovimab is a recombinant human monoclonal antibody that has been shown to prevent
progression to hospitalization or death in non‐hospitalized high‐risk patients with mild to …

Purpose Undergoing Roux-en-Y gastric bypass (RYGB) is expected to affect orally
administered drug absorption. Statins are commonly prescribed to patients with obesity for the …

… CORRECTION Correction to: Longitudinal Impacts of Gastric Bypass Surgery on
Pharmacodynamics and Pharmacokinetics of Statins Asma El-Zailik1 & Lily K. Cheung2 & …

Obesity is a major health concern, with 39.8% of adults in the US being obese in 2015-2016.
Bariatric surgery is the recommended treatment strategy for obese patients with a body …

Sotrovimab is a recombinant human monoclonal antibody that has been shown to prevent
progression to hospitalization or death from severe disease in non-hospitalized high-risk …

… Asma El-Zailik University of Houston … Asma El-Zailik1 & Lily K. Cheung2 & Yang
Wang1 & Vadim Sherman3 & Diana S.-L. … Asma El-Zailik and Lily K. Cheung contributed …

CZ48, a lactone-stabilized camptothecin (CPT), is a topoisomerase 1 enzyme inhibitor. Its
strong potential as an anticancer agent has been demonstrated against various types of …

… I’d also like to thank Asma El Zailik and my current colleagues Ahmed Abu-Fayyad and
Mohammad Hailat. Special thanks go to Dr. Akhtar Siddiqui, my senior and colleague for the …